Olanzapine ≥98%, crystalline solid
Dodavatel: Cayman Chemical
Olanzapine is an antipsychotic, thienobenzodiazepine compound that has been approved for use in the treatment of schizophrenia and bipolar disorder (formulated for human use under the name Zyprexa®).
Olanzapine binds as an antagonist/inverse agonist to dopamine D1 (Ki = 31 nM), dopamine D2 (Ki = 11 nM), dopamine D4 (Ki = 27 nM), serotonin 5-HT2A (Ki = 4 nM), serotonin 5-HT2C (Ki = 11 nM), serotonin 5-HT3 (Ki = 57 nM), muscarinic M1 (Ki = 2 nM), α1-adrenergic (Ki = 19 nM), and histamine H1 (Ki = 7 nM) receptors.
Olanzapine has a high affinity for dopamine D1 and D2 receptors (IC50s = 25 and 10 nM, respectively) in human striatal tissue and for 5-HT2A, 5-HT2C, muscarinic M1, and α1-adrenergic receptors (IC50s = 7, 71, 2, and 70 nM, respectively) in human frontal cortex.
Vzorec:
C₁₇H₂₀N₄S |
MDL Number:
MFCD00866702 CAS číslo: 132539-06-1 |
Výsledky specifikačního testu
Purity | ≥98% |
Stability | ≥2 years at −20 °C |
Form | Crystalline Solid |
UV/Vis | λmax: 226, 272 nm |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...